363 results
-
List item
Human medicine European public assessment report (EPAR): Vaxneuvance
pneumococcal polysaccharide conjugate vaccine (adsorbed), Pneumococcal Infections
Date of authorisation: 13/12/2021,
, Revision: 3, Authorised, Last updated: 29/11/2022
-
List item
Human medicine European public assessment report (EPAR): Gardasil
human papillomavirus type 6 L1 protein, human papillomavirus type 11 L1 protein, human papillomavirus type 16 L1 protein, human papillomavirus type 18 L1 protein, Papillomavirus Infections; Uterine Cervical Dysplasia; Condylomata Acuminata; Immunization
Date of authorisation: 20/09/2006, Revision: 48, Authorised, Last updated: 08/11/2022 -
List item
Human medicine European public assessment report (EPAR): Gardasil 9
human papillomavirus vaccine [types 6, 11, 16, 18, 31, 33, 45, 52, 58] (recombinant, adsorbed), Condylomata Acuminata; Papillomavirus Infections; Immunization; Uterine Cervical Dysplasia
Date of authorisation: 10/06/2015, Revision: 20, Authorised, Last updated: 08/11/2022 -
List item
Human medicine European public assessment report (EPAR): Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune)
reassortant influenza virus (live attenuated) of the following strain: A/Vietnam/1203/2004 (H5N1) strain, Influenza, Human
Date of authorisation: 20/05/2016,, 
, Revision: 9, Authorised, Last updated: 06/10/2022
-
List item
Veterinary medicine European public assessment report (EPAR): Nobilis OR Inac
inactivated whole cell suspension of Ornithobacterium rhinotracheale serotype A, strain B3263/91, Chicken
Date of authorisation: 24/01/2003, Revision: 7, Withdrawn, Last updated: 03/10/2022 -
List item
Human medicine European public assessment report (EPAR): Aflunov
influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/turkey/Turkey/1/05 (H5N1)-like strain (NIBRG-23), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 28/11/2010, Revision: 15, Authorised, Last updated: 03/10/2022 -
List item
Human medicine European public assessment report (EPAR): Vaxchora
vibrio cholerae, strain cvd 103-hgr, live, Cholera
Date of authorisation: 01/04/2020,, Revision: 6, Authorised, Last updated: 27/09/2022
-
List item
Human medicine European public assessment report (EPAR): HBVaxPro
hepatitis B, recombinant surface antigen, Hepatitis B; Immunization
Date of authorisation: 27/04/2001, Revision: 32, Authorised, Last updated: 16/08/2022 -
List item
Human medicine European public assessment report (EPAR): RotaTeq
rotavirus serotype G1, serotype G2, serotype G3, serotype G4, serotype P1, Immunization; Rotavirus Infections
Date of authorisation: 26/06/2006, Revision: 34, Authorised, Last updated: 16/08/2022 -
List item
Human medicine European public assessment report (EPAR): Ervebo
recombinant vesicular stomatitis virus (strain indiana) with a deletion of the envelope glycoprotein, replaced with the zaire ebolavirus (strain kikwit 1995) surface glycoprotein, Hemorrhagic Fever, Ebola
Date of authorisation: 11/11/2019,, Revision: 7, Authorised, Last updated: 04/08/2022
-
List item
Human medicine European public assessment report (EPAR): Supemtek
Influenza A virus subtype H1N1 haemagglutinin, recombinant, Influenza A virus subtype H3N2 haemagglutinin, recombinant, Influenza B virus Victoria lineage haemagglutinin, recombinant, Influenza B virus Yamagata lineage haemagglutinin, recombinant, Influenza, Human
Date of authorisation: 16/11/2020,, Revision: 2, Authorised, Last updated: 28/07/2022
-
List item
Human medicine European public assessment report (EPAR): ProQuad
virus, live attenuated, measles, virus, live attenuated, mumps, virus, live attenuated, rubella, virus, live attenuated, varicella, Chickenpox; Rubella; Measles; Mumps; Immunization
Date of authorisation: 05/04/2006, Revision: 31, Authorised, Last updated: 22/07/2022 -
List item
Human medicine European public assessment report (EPAR): M-M-RVaxPro
measles virus Enders’ Edmonston strain (live, attenuated), mumps virus Jeryl Lynn (level B) strain (live, attenuated), rubella virus Wistar RA 27/3 strain (live, attenuated), Rubella; Mumps; Immunization; Measles
Date of authorisation: 05/05/2006, Revision: 30, Authorised, Last updated: 14/07/2022 -
List item
Human medicine European public assessment report (EPAR): Zostavax
varicella-zoster virus (live, attenuated), Herpes Zoster; Immunization
Date of authorisation: 19/05/2006, Revision: 33, Authorised, Last updated: 01/07/2022 -
List item
Human medicine European public assessment report (EPAR): Rotarix
human rotavirus, live attenuated, Immunization; Rotavirus Infections
Date of authorisation: 21/02/2006, Revision: 40, Authorised, Last updated: 29/06/2022 -
List item
Human medicine European public assessment report (EPAR): Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)
split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 10/10/2009,
, Revision: 11, Authorised, Last updated: 08/06/2022
-
List item
Human medicine European public assessment report (EPAR): Nimenrix
Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid, Meningitis, Meningococcal
Date of authorisation: 20/04/2012, Revision: 35, Authorised, Last updated: 25/05/2022 -
List item
Human medicine European public assessment report (EPAR): Infanrix Hexa
Diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), hepatitis B surface antigen, poliovirus (inactivated) (type-1 (Mahoney strain), type-2 (MEF-1 strain), type-3 (Saukett strain)), Haemophilus influenzae type b polysaccharide, Hepatitis B; Tetanus; Immunization; Meningitis, Haemophilus; Whooping Cough; Poliomyelitis; Diphtheria
Date of authorisation: 23/10/2000, Revision: 44, Authorised, Last updated: 11/05/2022 -
List item
Human medicine European public assessment report (EPAR): Cervarix
human papillomavirus1 type 16 L1 protein, human papillomavirus type 18 L1 protein, Papillomavirus Infections; Uterine Cervical Dysplasia; Immunization
Date of authorisation: 20/09/2007, Revision: 38, Authorised, Last updated: 05/05/2022 -
List item
Human medicine European public assessment report (EPAR): Dukoral
recombinant cholera toxin B subunit, vibrio cholerae 01, Cholera; Immunization
Date of authorisation: 28/04/2004, Revision: 14, Authorised, Last updated: 06/04/2022 -
List item
Human medicine European public assessment report (EPAR): Foclivia
influenza virus surface antigens, inactivated: A/Viet Nam/1194/2004 (H5N1), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 18/10/2009,, Revision: 12, Authorised, Last updated: 06/04/2022
-
List item
Veterinary medicine European public assessment report (EPAR): Respiporc FLUpan H1N1
Influenza A virus/human strain: A/Jena/VI5258/2009 (H1N1)pdm09, inactivated, Pigs
Date of authorisation: 17/05/2017, Revision: 6, Authorised, Last updated: 21/03/2022 -
List item
Veterinary medicine European public assessment report (EPAR): Mhyosphere PCV ID
Mycoplasma hyopneumoniae, strain 7304 (Nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated, Pigs
Date of authorisation: 18/08/2020, Revision: 1, Authorised, Last updated: 14/02/2022 -
List item
Veterinary medicine European public assessment report (EPAR): Poulvac E. coli
Live aroA gene deleted Escherichia coli, type 078, strain EC34195, Chicken; Turkeys
Date of authorisation: 15/06/2012, Revision: 10, Authorised, Last updated: 11/02/2022 -
List item
Human medicine European public assessment report (EPAR): Dengvaxia
chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated), Dengue
Date of authorisation: 12/12/2018,, Revision: 3, Authorised, Last updated: 26/01/2022